Patient Education & Wellness
September 9, 2026

Why ClearPath Is Better for "Access" Procedures

Discover how ClearPath balloon-assisted septoplasty supports safer access in sinus & skull base surgery with less tissue disruption, better visualization, and e
Why ClearPath Is Better for "Access" Procedures

Why ClearPath Supports “Access” Procedures in Sinus & Skull Base Surgery

In ENT surgery, “access” means creating a safer, clearer pathway so an endoscope and instruments can move through the nose with better visibility and less crowding. When access is limited, the goal is often to open the nasal corridor while minimizing unnecessary tissue disruption—so patients can breathe better and surgeons can work more efficiently.

Septoplasty is very common, performed more than 250,000 times each year in the U.S., and newer approaches continue to focus on reducing dissection-related morbidity when appropriate.¹ This is where the ClearPath device—used for balloon-assisted septoplasty—often enters the conversation for access-focused goals. If you’re new to the technique, here’s a quick explainer on balloon-assisted septoplasty: https://www.clearpathnasal.com/blog/what-is-balloon-assisted-septoplasty

A useful way to think about it: if the septum is the “hallway,” sinus and skull base surgery can require moving a camera and instruments down that hallway. When the hallway is too narrow, everything becomes harder—visibility, precision, and comfort for the tissues along the way.

• In short: access aims to open the working corridor while preserving healthy tissue wherever possible.

About the evidence and terminology (read this first)

• The outcomes summarized below come from a single-center retrospective series using the ClearPath device (107 consecutive cases), with smaller imaging (n=23) and patient-reported outcome (n=43) subgroups and one-month follow-up for SNOT-22. Larger, prospective studies would be valuable to confirm and extend these findings.¹

• In that report, “major complications” refers to events the authors tracked and reported—specifically septal perforation, hematoma, synechia, or conversion to flap-based septoplasty.

• Bottom line: promising early data exist, but broader, prospective research is still needed.

What Are “Access Procedures” (and Why Does the Septum Matter)?

Septum as hallway before/after split

The septum as the “hallway” to the sinuses (and beyond)

The nasal septum is the wall that divides the left and right sides of the nose. If it’s significantly deviated, it can narrow one side of the nasal passage and create a pinch point—like a hallway that’s too tight to comfortably pass through.

For patients who need endoscopic sinus or skull base surgery, that narrow corridor can matter. A deviated septum may limit how easily an endoscope can see around key anatomy and can restrict instrument movement—especially when the surgeon needs stable lines of sight and room to work without repeatedly contacting sensitive nasal lining. For more on the surgical view, see how ClearPath improves visualization for surgeons: https://www.clearpathnasal.com/blog/how-clearpath-improves-visualization-for-surgeons

In real life, “access procedures” can include situations such as:

• Endoscopic sinus surgery for chronic sinusitis

• Endoscopic approaches where visualization is critical

• Revision cases, where scarring or anatomy can already be challenging

When people search for ClearPath access procedures, they’re often really asking: can the nasal corridor be improved in a way that supports the rest of the planned surgery—without “overdoing” tissue disruption? For a deeper dive on this exact use-case, see balloon septoplasty for sinus & skull base access: https://www.clearpathnasal.com/blog/balloon-septoplasty-for-sinus-skull-base-access-new-frontiers

Symptoms patients notice vs. what surgeons see

Patients may notice:

• Persistent congestion or blockage on one side

• Facial pressure or headache

• Poor sleep quality or mouth breathing

Surgeons may see:

• Tight working space and instrument crowding

• Reduced visualization

• Increased likelihood of mucosal irritation from repeated instrument contact

A key point: even if symptoms are the main reason you’re seeking care, the “access” side of the equation can still influence which septum-straightening approach your ENT recommends—particularly when another endoscopic procedure is planned.

• Takeaway: access matters both for what the surgeon can do safely and what patients can feel day-to-day.

The Traditional Approach to Creating Access (and Its Tradeoffs)

Traditional vs minimally disruptive

Traditional septoplasty (high-level overview)

Traditional septoplasty typically involves lifting the lining over the cartilage and bone (mucoperichondrial flap elevation), then reshaping or repositioning portions of the septum to improve alignment. This can be very effective, but it may come with patient concerns such as:

• More swelling and tenderness early on

• Bleeding risk (usually manageable, but still a consideration)

• A recovery period that can feel “stuffy” while tissues settle

For some patients, traditional septoplasty is absolutely the right fit. For others—especially when the primary goal is to create space for endoscopic work—ENTs may consider approaches that aim for meaningful corridor improvement with less dissection, when anatomy allows. For a side-by-side look at tradeoffs and expectations, see ClearPath vs. traditional septoplasty: https://www.clearpathnasal.com/blog/clearpath-vs-traditional-septoplasty-recovery-safety-results

Why “less disruption” is a major goal in modern ENT

Your nasal lining plays an important role in comfort and healing. When a technique can achieve improved alignment while preserving as much healthy lining as possible, it may support a smoother early recovery experience for some patients—particularly those who are already facing sinus or skull base surgery.

• Summary: traditional septoplasty works well for many, but less-disruptive options may fit access-first goals when anatomy permits.

How ClearPath Changes the Access Conversation (Balloon-Assisted Septoplasty)

ClearPath’s minimally invasive intent (how it works—plain language)

ClearPath is a device used for balloon-assisted septoplasty. In the published clinical report, the technique uses a force-directed balloon along with a shaped spatula to mobilize bony septal deviations, with the intent of reducing or avoiding mucoperichondrial flap elevation, packing, and prolonged anesthesia compared with traditional septoplasty.²

What “force-directed” means for access

Force-directed balloon at the choke point

“Force-directed” refers to applying controlled, targeted force to the deviation rather than broadly disrupting tissue. Think of it like straightening a bent section at the tightest choke point, instead of remodeling the entire hallway.

For patients considering ClearPath access procedures, the practical idea is straightforward: if the narrowest part of the corridor can be improved in a focused way, it may create more room for the endoscope and instruments, and it may improve visualization—especially in areas where small changes in space can make a noticeable difference in working comfort. For additional context, see how ClearPath improves visualization for surgeons: https://www.clearpathnasal.com/blog/how-clearpath-improves-visualization-for-surgeons

• In essence: targeted, force-directed correction aims to open the pinch point without unnecessary tissue disruption.

Why ClearPath Can Support Surgical Access

Visualization gain from the scope’s perspective

Better access starts with alignment where it matters

Not all deviations are equally important for access. Surgeons often pay close attention to the tightest spot—sometimes called the point of maximal deviation—because that “pinch point” is where the corridor is most limited.

In a subset of patients who had both pre- and post-operative CT scans (n=23), septal alignment improved by a mean of 45% at the point of maximal deviation and 22% at the nasolacrimal duct, with both findings statistically significant (p=0.005).³ The same report noted that 78% achieved at least a 30% improvement and none worsened in this CT subgroup.³ These imaging findings suggest measurable anatomic changes at key locations that can influence corridor size and visualization during endoscopic work. For access-specific insights, see balloon septoplasty for sinus & skull base access: https://www.clearpathnasal.com/blog/balloon-septoplasty-for-sinus-skull-base-access-new-frontiers

Better access should still feel better to the patient

Even when access is the primary driver, patients still care about day-to-day symptoms. In the published series, 43 patients completed a SNOT-22 questionnaire at one month. Scores improved from a mean of 58.7 to 44.8, a 23.8% reduction (p=0.02).⁴ The largest improvements were reported in nasal congestion, headache/facial pressure, and sleep quality.⁴

Safety observations aligned with minimally invasive goals

Safety is central to any septoplasty discussion. In the same report, across 107 consecutive cases, there were no major complications observed—as defined by the authors—including no septal perforation, hematoma, synechia, or conversion to traditional flap-based surgery.⁵ While no procedure can be promised risk-free, this finding supports the idea that the device is designed around minimally invasive goals—and that those goals were reflected in the observed outcomes in this series.

• Takeaway: early data point to corridor gains on imaging, symptom improvement at one month, and a safety profile consistent with minimally invasive aims—pending confirmation in larger prospective studies.

What to Expect If ClearPath Is Used to Improve Access

Before the procedure

Most patients start with:

• A symptom review (breathing, congestion, pressure, sleep)

• A nasal exam (often with endoscopic evaluation in the office)

• Sometimes a CT scan, especially when planning sinus/skull base surgery or evaluating complex anatomy

Your surgeon should explain whether the goal is breathing improvement alone, improved access for another procedure, or both. That distinction matters, because “access first” planning often focuses on the tightest corridor limitations rather than maximizing every possible structural change.

During the procedure (a simple walkthrough)

While each practice varies, the general idea is:

• Endoscopic guidance is used to visualize anatomy

• The ClearPath device is used to apply targeted dilation and mobilization where the septum is deviated

• The intent is focused correction at the areas that limit corridor and visualization

Comparing approaches? Here’s a practical overview: ClearPath vs. traditional septoplasty: https://www.clearpathnasal.com/blog/clearpath-vs-traditional-septoplasty-recovery-safety-results

Recovery and follow-up

Common early experiences after septal work can include:

• Congestion or stuffiness

• Mild pressure or tenderness

• Temporary changes in airflow as swelling improves

Call your surgeon’s office promptly if you have:

• Bleeding that does not slow down with the steps your care team recommends

• Fever

• Worsening pain (instead of gradual improvement)

• New or concerning symptoms that feel out of proportion

• In brief: expect focused correction with endoscopic guidance and a recovery that typically centers on managing short-term swelling and congestion.

Who May Benefit Most From ClearPath for Access?

Common “good fit” scenarios

ClearPath access procedures are often considered when:

• A deviation significantly narrows the endoscopic corridor

• Better space and visualization would help a planned sinus or skull base approach

• A minimally invasive septoplasty approach is appropriate for the specific anatomy

A practical example: a patient scheduled for endoscopic sinus surgery who has a pronounced septal pinch point on the side the surgeon needs to work through. In that scenario, “making room” is less about cosmetic straightness and more about creating a functional pathway for safe instrument movement.

When another approach may be recommended

Not every deviation is the same. Some septal problems (or combined issues involving other structures) may still require a different surgical plan.

It’s also worth noting that the published report was retrospective, and the CT subgroup was smaller (n=23), meaning larger prospective studies would be helpful for broader conclusions.¹

• Net-net: ClearPath may be a strong option when the pinch point limits the corridor and the anatomy suits a minimally disruptive approach.

Questions to Ask Your ENT Surgeon (Patient Checklist)

Bring these to your consultation:

• Is my septum limiting access for my planned endoscopic procedure?

• Am I a candidate for balloon-assisted septoplasty using the ClearPath device?

• What results do you track after surgery (symptom scores, nasal endoscopy findings, imaging when needed)?

• What is the recovery plan and follow-up schedule?

• If my anatomy is complex, what are the alternatives and why?

• Quick tip: align on whether the priority is breathing, access for another procedure, or both.

Key Takeaways (Quick Scan)

Key outcomes at a glance

• ClearPath is a balloon-assisted septoplasty device intended to reduce tissue disruption compared with traditional flap-based methods in appropriate cases.²

• In a published series, no major complications were observed across 107 cases, as defined by the authors (no septal perforation, hematoma, synechia, or conversion).⁵

• Patients who completed SNOT-22 at one month reported an average ~24% improvement.⁴

• In a CT subset, septal alignment improved 45% at maximal deviation and 22% at the nasolacrimal duct.³

• Evidence to date is from a single-center retrospective series with modest subgroups; larger, prospective studies are warranted.¹

• Short version: early results are encouraging, and ongoing research will clarify where this approach fits best.

FAQ

1) What does “access” mean in sinus or skull base surgery?

Access refers to creating enough space and visibility inside the nose for an endoscope and instruments to reach the target area safely and efficiently.

2) Can fixing a deviated septum improve surgical visualization?

Yes. A deviated septum can narrow the corridor and limit scope movement. Improving alignment may create more room and better lines of sight.

3) Is balloon-assisted septoplasty safer than other approaches?

Safety depends on anatomy, goals, and technique. In one published report of 107 ClearPath cases, no major complications were observed—as defined by the authors—but individual risk varies.⁵

4) How soon can I breathe better after ClearPath?

In the published series, symptom scores improved at one month in patients who completed follow-up questionnaires.⁴ Your timeline can differ based on swelling, healing, and any additional procedures.

5) Will I still need a different septoplasty approach in some cases?

Possibly. Some deviations or combined anatomic issues may require a different plan. Your ENT can explain which approach best matches your anatomy and surgical goals.

Conclusion — The ClearPath Takeaway for Access Procedures

When the septum is the main barrier to a clear endoscopic corridor, the ClearPath device may be a compelling option for access-focused goals in appropriately selected patients:

• Designed to support minimally invasive intent (less flap elevation/packing in appropriate cases).²

• Demonstrated CT alignment gains in a subset, including improvement at maximal deviation.³

• Reported symptom improvement and favorable safety observations in a 107-case series.⁴⁵

CTA: If you’ve been told your septum is limiting surgical access—or you suspect your deviation is contributing to congestion and poor airflow—ask your local ENT whether ClearPath access procedures could be a fit for your anatomy and your surgical plan, and how it compares with a traditional septoplasty approach for your specific goals.

This article is for educational purposes only and is not medical advice. Please consult a qualified healthcare provider for diagnosis and treatment.

References

1. Dillard J, et al. ClearPath Nasal Balloon (CNB) septoplasty outcomes. Rhinology Online. 2026 (forthcoming).

2–5. Ibid. (Technique description, CT outcomes, SNOT-22 outcomes, and safety observations reported within the same publication.)

Dr. David G. Dillard
Author
Share it with others!

ClearPath™ is a prescription medical device. This information is for educational purposes only and is not medical advice. Only a qualified physician can determine whether ClearPath™ is appropriate for you.